A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC)

NCT00002254 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Alovudine

Sponsor

Lederle Laboratories